NOX inhibitors - A promising avenue for ischemic stroke

Jong Youl Kim, Joohyun Park, Jong Eun Lee, Midori A. Yenari

Research output: Contribution to journalReview articlepeer-review

16 Citations (Scopus)

Abstract

NADPH-oxidase (NOX) mediated superoxide originally found on leukocytes, but now recognized in several types of cells in the brain. It has been shown to play an important role in the progression of stroke and related cerebrovascular disease. NOX is a multisubunit complex consisting of 2 membrane-associated and 4 cytosolic subunits. NOX activation occurs when cytosolic subunits translocate to the membrane, leading to transport electrons to oxygen, thus producing superoxide. Superoxide produced by NOX is thought to function in long-term potentiation and intercellular signaling, but excessive production is damaging and has been implicated to play an important role in the progression of ischemic brain. Thus, inhibition of NOX activity may prove to be a promising treatment for ischemic brain as well as an adjunctive agent to prevent its secondary complications. There is mounting evidence that NOX inhibition in the ischemic brain is neuroprotective, and targeting NOX in circulating immune cells will also improve outcome. This review will focus on therapeutic effects of NOX assembly inhibitors in brain ischemia and stroke. However, the lack of specificity and toxicities of existing inhibitors are clear hurdles that will need to be overcome before this class of compounds could be translated clinically.

Original languageEnglish
Pages (from-to)195-205
Number of pages11
JournalExperimental Neurobiology
Volume26
Issue number4
DOIs
Publication statusPublished - 2017 Aug 1

Bibliographical note

Funding Information:
This study was funded by grants from the National Institutes of Health (RO1 NS40516), Department of Defense and the Veteran's Merit Award (I01 BX000589) to MAY, Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1D-1A1B03933017) to JYK and a National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT & Future Planning (NRF-2016M3C7A1905098) to JEL. Grants to MAY was administered by the Northern California Institute for Research and Education, and supported by resources of the Veterans Affairs Medical Center, San Francisco, California

Publisher Copyright:
© Experimental Neurobiology 2017.

All Science Journal Classification (ASJC) codes

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'NOX inhibitors - A promising avenue for ischemic stroke'. Together they form a unique fingerprint.

Cite this